Identifying placental metabolic biomarkers of preterm birth using nuclear magnetic resonance of intact tissue samples

• DOI: 10.1016/j.placenta.2023.10.006
• Publication Date: 2023-10-12T01:40:51Z
• Authors: Grace V. Mercer; Darcie Stapleton; Catherine Barrett; Lauren C.M. Ringer; Stacy Lambe; Amanda Critch; Gabrielle Newman; Ashley Pelley; Rajshree Ghosh Bi...; William Wolff; Flavio Crizostomo...; Ronald Soong; André J. Simpson; Lindsay S. Cahill
• Keywords: Magnetic Resonance Spectroscopy; Placenta Diseases; Pregnancy; Placenta; Infant, Newborn; Humans; Premature Birth; Female; Valine; Biomarkers; 3. Good health

Our understanding of the etiology of preterm birth (PTB) is incomplete; however, recent evidence has found a strong association between placental dysfunction and PTB. Altered placental metabolism may precede placental dysfunction and therefore the study of placental metabolic profiles could identify early biomarkers of PTB. In this study, we evaluated the placental metabolome in PTB in intact tissue samples using nuclear magnetic resonance (NMR) and spectral editing.Placental tissue samples were collected from nine term pregnancies and nine preterm pregnancies (<37 weeks' gestation). 1H NMR experiments on unprocessed tissue samples were performed using a high field magnet (500 MHz spectrometer) and a comprehensive multiphase NMR probe. The relative concentrations of 23 metabolites were corrected for gestational age and compared between groups.The relative concentration of valine, glutamate and creatine were significantly decreased while alanine, choline and glucose were elevated in placentas from PTB pregnancies compared to controls (p < 0.05). Multivariate analysis using principal component analysis showed the PTB and control groups were significantly separated (p < 0.0001) and pathway analysis identified perturbations in the glycine, serine and threonine metabolism, aminoacyl-tRNA biosynthesis and valine, leucine and isoleucine biosynthesis pathways.PTB is associated with significant alterations in placental metabolism. This study helps improve our understanding of the etiology of PTB. It also highlights the potential for small molecule metabolites to serve as placental metabolic biomarkers to aid in the prediction and diagnosis of PTB. The results can be translated to clinical use via in utero magnetic resonance spectroscopy.